IN BRIEF (Page 19)

New AIDS drug brings hope

Medical researchers have unveiled clinical trials of a new anti-AIDS drug that better controls the spread of the deadly virus among previously untreated patients.

Developed by US pharmaceutical giant Merck and Co, Isentress is the first of a new type of anti-AIDS drug called an HIV integrase inhibitor, based on the enzyme that controls HIV virus reproduction.